European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Overview
European Neuropsychopharmacology is a renowned journal published by the European College of Neuropsychopharmacology. It focuses on the latest research in the field of neuropsychopharmacology, covering topics such as the neurobiology of psychiatric disorders, psychopharmacology, and clinical trials. With a strong emphasis on European research, the journal provides a platform for scientists, clinicians, and researchers to share their findings and advancements in this rapidly evolving field.
Details
Details
Abbr.
Eur Neuropsychopharmacol
Publisher
Elsevier
Start
1990
End
Continuing
Frequency
6 no. a year, 1999-
p-ISSN
0924-977X
e-ISSN
1873-7862
Country
Netherlands
Language
English
Specialties
Pharmacology
Psychiatry
Psychiatry
Metrics
Metrics
h-index / Ranks: 1919
130
SJR / Ranks: 1488
1756
CiteScore / Ranks: 1928
8.70
JIF / Ranks: 1276
5.6
Recent Articles
1.
2.
Gonzalez-Campos M, Vieta E
Eur Neuropsychopharmacol
. 2025 Mar;
95:4-5.
PMID: 40057994
No abstract available.
3.
Erkizia-Santamaria I, Meana J, Ortega J
Eur Neuropsychopharmacol
. 2025 Mar;
95:2-3.
PMID: 40057993
No abstract available.
4.
Llach C, Le G, Badulescu S, Anmella G, Hasan H, Gimenez-Palomo A, et al.
Eur Neuropsychopharmacol
. 2025 Mar;
94:59-75.
PMID: 40057988
Extracellular vesicles (EVs) are small, membrane-bound particles that are naturally released by nearly all cell types in the body. They serve as molecular biosignatures, reflecting the state of their cells...
5.
Hung T, Hsu Y, Chen Y, Hsu C
Eur Neuropsychopharmacol
. 2025 Mar;
93:22-23.
PMID: 40057373
No abstract available.
6.
Tian J, Siafis S, Lin X, Wu H, Johannes S, Stefan L
Eur Neuropsychopharmacol
. 2025 Mar;
94:51-58.
PMID: 40056667
Background: High discontinuation rates compromise the effectiveness of treatment regimens for schizophrenia, because consistent medication adherence is essential for the efficacy of antipsychotics. Understanding the relationship between antipsychotic doses and...
7.
Geck S, Roithmeier M, Buhner M, Wehr S, Weigel L, Priller J, et al.
Eur Neuropsychopharmacol
. 2025 Mar;
94:41-50.
PMID: 40056666
The Positive and Negative Syndrome Scale (PANSS-30) is the standard instrument for assessing symptoms of schizophrenia and related psychotic disorders. However, its long administration time and structural issues have prompted...
8.
Bavato F, Quednow B
Eur Neuropsychopharmacol
. 2025 Mar;
94:39-40.
PMID: 40056665
No abstract available.
9.
10.
Salazar de Pablo G, Catalan A, Rogdaki M, Dazzan P
Eur Neuropsychopharmacol
. 2025 Mar;
94:36-37.
PMID: 40056663
No abstract available.